Find uplifting stories about heroes, innovations, and solutions
2 results for "iga nephropathy"
After decades of limited options, five new therapies have been approved for IgA nephropathy, a kidney disease that affects millions worldwide. Doctors say this is just the beginning of a treatment revolution.
After decades of limited options, patients with IgA nephropathy now have access to the first treatment that targets the root cause of their disease. The FDA approved sibeprenlimab in late 2025, bringing hope to thousands living with this progressive kidney condition.